Interpretation of the essential updates in guidelines for the prevention and treatment of chronic hepatitis B (Version 2022)

Hong YOU; Ya-Meng SUN; Meng-Yang ZHANG; Yue-Min NAN; Xiao-Yuan XU; Tai-Sheng LI; Gui-Qiang WANG; Jin-Lin HOU; Zhongping DUAN; Lai WEI; Fu-Sheng WANG; Ji-Dong JIA; Hui ZHUANG

Interpretation of the essential updates in guidelines for the prevention and treatment of chronic hepatitis B (Version 2022) / 中华肝脏病杂志

Hong YOU; Ya-Meng SUN; Meng-Yang ZHANG; Yue-Min NAN; Xiao-Yuan XU; Tai-Sheng LI; Gui-Qiang WANG; Jin-Lin HOU; Zhongping DUAN; Lai WEI; Fu-Sheng WANG; Ji-Dong JIA; Hui ZHUANG.

Chinese Journal of Hepatology ; (12): 385-388, 2023.

Article in Chinese | WPRIM | ID: wpr-986142

ABSTRACT

ABSTRACT

Chinese Society of Hepatology and Chinese Society of Infectious Diseases, Chinese Medical Association update the guidelines for the prevention and treatment of chronic hepatitis B (version 2022) in 2022. The latest guidelines recommend more extensive screening and more active antiviral treating for hepatitis B virus infection. This article interprets the essential updates in the guidelines to help deepen understanding and better guide the clinical practice.

Subject(s)

Humans; Hepatitis B, Chronic/drug therapy; Hepatitis B/drug therapy; Hepatitis B virus; Antiviral Agents/therapeutic use; Gastroenterology

Chronic hepatitis B; Guideline; Interpretation; Update

Fulltext

XML

Search on Google

Full text: Available Index: WPRIM (Western Pacific) Main subject: Antiviral Agents / Hepatitis B virus / Hepatitis B, Chronic / Gastroenterology / Hepatitis B Limits: Humans Language: Chinese Journal: Chinese Journal of Hepatology Year: 2023 Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

Search on Google